| Literature DB >> 34888711 |
Lea Timmermann1, Karl Herbert Hillebrandt1,2, Matthäus Felsenstein1,2, Moritz Schmelzle1, Johann Pratschke1, Thomas Malinka3,4.
Abstract
INTRODUCTION: Establishing a sufficient pancreatico-enteric anastomosis remains one of the most important challenges in open single stage pancreatoduodenectomy as they are associated with persisting morbidity and mortality. Applicability on a robotic-assisted approach, however, even increases the requirements. With this analysis we introduce a dorsal-incision-only invagination type pancreatogastrostomy (dioPG) to the field of robotic assistance having been previously proven feasible in the field of open pancreatoduodenectomy and compare initial results to the open approach by means of morbidity and mortality.Entities:
Keywords: Pancreato-enteric anastomosis; Pancreatoduodenectomy; Pancreatogastrostomy; Robotic-assisted
Mesh:
Year: 2021 PMID: 34888711 PMCID: PMC9402518 DOI: 10.1007/s00464-021-08925-w
Source DB: PubMed Journal: Surg Endosc ISSN: 0930-2794 Impact factor: 3.453
Fig. 1dioPG in progress. Figure shows the anastomosis in progress with the untied purse-string and mattress sutures
Patients’ characteristics
| Characteristics | All patients ( | RPG ( | OPG ( | |
|---|---|---|---|---|
| Sex | 0.431 | |||
| Male | 82 (57.7) | 21 (55.3) | 61 (58.7) | |
| Female | 60 (42.3) | 17 (44.7) | 43 (41.3) | |
| Age (years) | ||||
| Mean | 66.4 | 61.5 | 68.1 | |
| Minimum | 37 | 37 | 38 | |
| Maximum | 88 | 78 | 88 | |
| ASA score | 0.231 | |||
| 1 | 4 (3) | 0 (0) | 4 (4) | |
| 2 | 67 (49.6) | 18 (51.4) | 49 (49) | |
| 3 | 63 (46.7) | 16 (45.7) | 47 (47) | |
| 4 | 1 (0.7) | 1 (2.9) | 0 (0) | |
| BMI | 0.931 | |||
| Mean | 25.1 | 24.9 | 25.08 | |
| Minimum | 17 | 17 | 17 | |
| Maximum | 42 | 40 | 42 | |
| Underlying malignancy | 108 (76.1) | 22 (57.9) | 86 (82.7) | |
| Indication | ||||
| PDAC | 62 (43.7) | 10 (26.3) | 52 (50) | |
| Extrahepatic cholangiocarcinoma | 18 (12.7) | 6 (15.8) | 12 (11.5) | |
| Papillary carcinoma | 13 (9.2) | 5 (13.2) | 8 (7.7) | |
| Duodenal carcinoma | 3 (2.1) | 1 (2.6) | 2 (1.9) | |
| GIST | 5 (3.5) | 0 (0) | 5 (4.8) | |
| Other (malignant) | 7 (4.9) | 0 (0) | 7 (6.7) | |
| Pancreatitis | 17 (12) | 6 (15.8) | 11 (10.6) | |
| IPMN | 11 (7.7) | 7 (18.4) | 4 (3.8) | |
| Other (benign) | 6 (4.2) | 3 (7.9) | 3 (2.9) | |
| T-stage | 0.096 | |||
| T1 | 16 (15.5) | 6 (27.3) | 10 (12.3) | |
| T2 | 48 (46.6) | 12 (54.5) | 36 (44.4) | |
| T3 | 31 (30.1) | 4 (18.2) | 27 (33.3) | |
| T4 | 8 (7.8) | 0 (0) | 8 (9.9) | |
| Tumor diameter (mm) | ||||
| Mean | 28 | 19 | 30.5 | |
| Minimum | 1 | 6 | 1 | |
| Maximum | 120 | 34 | 120 |
Table indicated baseline characteristics of patients receiving either open or robotic-assisted pancreatoduodenectomy
ASA American Society of Anesthesiologists, BMI Body Mass Index, PDAC pancreatic ductal adenocarcinoma, GIST gastrointestinal stroma tumor, IPMN intraductal papillary mucinous neoplasm
Perioperative parameters and complications
| Characteristics | All patients ( | RPG ( | OPG ( | |
|---|---|---|---|---|
| R0 resection state | 80 (76.9) | 19 (86.4) | 61 (74.4) | 0.448 |
| Operation time (min) | ||||
| Mean | 269.3 | 286.2 | 263.1 | |
| Minimum | 134 | 210 | 134 | |
| Maximum | 437 | 382 | 437 | |
| Overall complications | 92 (64.8) | 23 (60.5) | 69 (66.3) | 0.520 |
| Clavien/dindo classification | 0.260 | |||
| 0 | 49 (34.5) | 14 (36.8) | 35 (33.7) | |
| 1 | 9 (6.3) | 1 (2.6) | 8 (7.7) | |
| 2 | 14 (9.9) | 3 (7.9) | 11 (10.6) | |
| 3a | 36 (25.4) | 11 (28.9) | 25 (24) | |
| 3b | 7 (4.9) | 1 (2.6) | 6 (5.8) | |
| 4a | 17 (12) | 3 (7.9) | 14 (13.5) | |
| 4b | 2 (1.4) | 2 (5.3) | 0 (0) | |
| 5 | 8 (5.6) | 3 (7.9) | 5 (4.8) | |
| POPF | 0.332 | |||
| Biochemical leak | 3 (2.1) | 0 (0) | 3 (2.9) | |
| B | 22 (15.5) | 8 (21.1) | 14 (13.5) | |
| C | 0 (0) | 0 (0) | 0 (0) | |
| PPH | 0.242 | |||
| A | 9 (6.3) | 1 (2.6) | 8 (7.7) | |
| B | 10 (7) | 2 (5.3) | 8 (7.7) | |
| C | 5 (3.5) | 3 (7.9) | 2 (1.9) | |
| SSI | 13 (9.2) | 3 (7.9) | 10 (9.6) | 0.753 |
| DGE | 13 (9.2) | 4 (10.5) | 9 (8.7) | 0.732 |
| PG-insufficiency | 16 (11.3) | 7 (18.4) | 9 (8.7) | 0.103 |
| Insufficiency hepaticojejunostomy | 7 (4.9) | 1 (2.6) | 6 (5.8) | 0.445 |
| Reoperation rate | 16 (11.3) | 7 (18.4) | 9 (8.7) | 0.103 |
| Intervention | 53 (37.3) | 15 (39.4) | 38 (36.5) | 0.250 |
| 30-day mortality | 6 (4.2) | 2 (5.3) | 4 (3.8) | 0.710 |
| 90-day readmission rate | 17 (12) | 3 (7.9) | 14 (13.5) | 0.366 |
| In-hospital stay (days) | ||||
| Mean | 18.08 | 18.9 | 17.76 | 0.617 |
| Minimum | 3 | 3 | 3 | |
| Maximum | 68 | 68 | 59 |
Table compares perioperative complications and outcome parameters for patients receiving either open or robotic-assisted pancreatoduodenectomy
POPF postoperative pancreatic fistula, PPH postoperative pancreatic hemorrhage, SSI surgical site infection, DGE delayed gastric emptying, PG pancreatogastrostomy